Teleocidins and benzolactams inhibit cell killing by human immunodeficiency virus type 1 (HIV-1).
Teleocidin B-4 and structurally related synthetic benzolactams were found to be potent inhibitors of cell killing by HIV-1. One of the benzolactams, (-)-BL-V8-310, showed a high selectivity index.